pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT02799004: How Much Opioids Do You Need After Your Emergency Department Visit

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Phase: . Conditions: Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07141004: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Sponsor: Johnson & Johnson Private Limited. Phase: PHASE4. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07132684: Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE3. Conditions: AML, Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07466433: Apical Preparation Size in Regenerative Endodontics of Mature Teeth

Sponsor: Marmara University. Phase: NA. Conditions: Apical Periodontitis, Mature Teeth, Regenerative Endodontic Treatment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372352: Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Peripheral T Cells Lymphoma (PTCL)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06974149: Effects of Transcranial Direct Current Stimulation Associated With Neurofunctional Rehabilitation in Individuals With Spinocerebellar Ataxias

Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Ataxias Espinocerebelares

full page →ctgov ↗
›COMPLETEDphase readoutNCT05751655: Observational Study of Drowning Patient's Emergency Care in Its Pre-hospital Phase.

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: . Conditions: Drowning

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07602855: A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05500326: Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: Scabies; Itch, Scabies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06258278: Clinical Results of Arthroscopic-Assisted Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears

Sponsor: Gazi University. Phase: NA. Conditions: Massive Irreparable Rotator Cuff Tears

full page →ctgov ↗
›RECRUITINGphase readoutNCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Solid Cancer, Metastatic Solid Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05972343: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Sponsor: Washington University School of Medicine. Phase: . Conditions: Breast Cancer, Cancer of the Breast

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02810743: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

Sponsor: The Netherlands Cancer Institute. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07561515: Integrative Use of Sound Therapy for Mental Health Promotion

Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Sound Therapy, Music Therapy, Mental Health, Anxiety, Stress, Depression, Quality of Life, Acoustic Resonance, Insonia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07400315: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07066215: Effects of Balance and Muscle Strength in Knee Osteoarthritis

Sponsor: Bezmialem Vakif University. Phase: . Conditions: Primary Knee Osteoarthritis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07336615: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

Sponsor: ClostraBio Inc.. Phase: NA. Conditions: Gastrointestinal, Overweight , Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477015: Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Autoimmune Encephalitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890078: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pneumocystis, Immunocompromised Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT05348785: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Sponsor: Biogen. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06344143: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Sponsor: The Cleveland Clinic. Phase: . Conditions: Mild Autonomous Cortisol Secretion (MACS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07114315: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Sponsor: Akeso. Phase: PHASE2. Conditions: Pancreatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05688215: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03059485: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06309485: Phase 2 Study of WGI-0301 for Advanced HCC

Sponsor: Zhejiang Haichang Biotech Co., Ltd.. Phase: PHASE2. Conditions: Advanced Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05849285: Evaluation of the Transitional and Lifelong Care Program

Sponsor: Western University, Canada. Phase: . Conditions: Cerebral Palsy, Spina Bifida, Developmental Disability

full page →ctgov ↗
›COMPLETEDphase readoutNCT07501312: Remote Microphone Performance Comparison in Adults With Hearing Loss

Sponsor: Sonova AG. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07423312: Lead Exposure and Multiple Sclerosis

Sponsor: Assiut University. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445828: Evaluation of Capsule Colonoscopy in Patients With Lynch Syndrome

Sponsor: Region Skane. Phase: . Conditions: Lynch Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07352228: Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

Sponsor: Xijing Hospital. Phase: PHASE4. Conditions: Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol

full page →ctgov ↗
›COMPLETEDphase readoutNCT07429565: Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients

Sponsor: University of Liverpool. Phase: PHASE1. Conditions: Osteoarthritis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06731465: Efficiency, Efficacy, Periodontal & Occlusal Outcomes for Aligners Versus Fixed Orthodontic Appliances in Crowded Incisor Treatment

Sponsor: University of Sharjah. Phase: NA. Conditions: Crowding of Anterior Mandibular Teeth

full page →ctgov ↗
›COMPLETEDphase readoutNCT03194165: Population Pharmacokinetics of Antiretroviral in Children

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

full page →ctgov ↗
›RECRUITINGphase readoutNCT00756665: Prostate Active Surveillance Study

Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms

full page →ctgov ↗
›COMPLETEDphase readoutNCT07500467: Upadacitinib for Refractory Takayasu Arteritis

Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04681807: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04993807: Data-driven SDM to Reduce Symptom Burden in AF

Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement

full page →ctgov ↗
›RECRUITINGphase readoutNCT06442592: Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07455136: A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06953336: Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT05361811: Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07282171: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

Sponsor: Comanche Biopharma. Phase: PHASE1. Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics

full page →ctgov ↗
›COMPLETEDphase readoutNCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Sponsor: Sun Pharmaceutical Industries Limited. Phase: PHASE3. Conditions: Active Psoriatic Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07195864: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

Sponsor: SIFI SpA. Phase: . Conditions: Acanthamoeba Keratitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05786664: Breast Cancer Survivorship Biorepository

Sponsor: University of Southern California. Phase: . Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07320209: Physiological and Neurocognitive Responses to Multisensory Food Cues in VR

Sponsor: Marmara University. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT07609732: Outcomes of Conventional Root Canal Treatment Compared to Regenerative Endodontics, and Cleaning and Shaping Only in Mature Upper First Premolars

Sponsor: Ain Shams University. Phase: NA. Conditions: Regenerative Endodontic Treatment, Cleaning and Shaping Only With Proper Coronal Seal, Necrotic Mature First Premolar

full page →ctgov ↗
← prev
page 97 of 161
next →